Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin for Cannabinoid Hyperemesis Syndrome
NCT04283292Phase 4Completed
- Sponsor
- University of Virginia
- Start
- Dec 2020
- Primary completion
- Mar 2022
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of capsaicin 8% patch in Cannabinoid hyperemesis syndrome (CHS), sponsored by University of Virginia. Started Dec 2020; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
Cannabinoid hyperemesis syndrome (CHS)
Beyond the preview
Go deeper on NCT04283292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283292.